Gene · 55894
Papers2,388
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,388
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unveiling balanced prenatal microbial colonization in amniotic fluid through an integrated culture and sequencing approach. | J Transl Med | 2026 | 41514270 | PubTator, text mining | PubMed |
| Mapping the structural and dynamic behavior of an antimicrobial peptide transporter from non-typeable Haemophilus influenzae. | Int J Biol Macromol | 2026 | 41390022 | PubTator, text mining | PubMed |
| Human beta-defensin 3-functionalized Fe/GMP nanozyme for multifunctional antimicrobial and anticancer activity against Helicobacter pylori-associated gastrointestinal cancer. | J Biotechnol | 2026 | 41314256 | PubTator, text mining | PubMed |
| The Role of Pan-Cytokeratin In Tumor Budding Upgrading In Malignant Colorectal Polyps At Stage pT1. | Cancer Manag Res | 2025 | 41403817 | PubTator, text mining | PubMed |
| Pathological and Clinical Significance of Tumor Budding and Its Association with Epithelial-Mesenchymal Transition in Colorectal Carcinoma: A Retrospective Observational Study. | Iran J Med Sci | 2025 | 41262322 | PubTator, text mining | PubMed |
| Designing of multi-epitope vaccine against Varicella zoster virus (VZV) using immunoinformatics and structural analysis: In silico study. | Bioimpacts | 2025 | 41185870 | PubTator, text mining | PubMed |
| Stability and biocompatibility of hBD3 with different chiral configurations and their therapeutic efficacy in periodontitis. | iScience | 2025 | 41142128 | PubTator, text mining | PubMed |
| CGREF1 promotes cancer cell migration and predicts poor prognosis in colorectal cancer. | J Cancer Res Clin Oncol | 2025 | 41125935 | PubTator, text mining | PubMed |
| The Role of Visfatin/NAMPT in the Pathogenesis of Psoriasis. | Metabolites | 2025 | 41002974 | PubTator, text mining | PubMed |
| Structure-Antimicrobial Activity Relationships of Recombinant Host Defence Peptides Against Drug-Resistant Bacteria. | Microb Biotechnol | 2025 | 40985079 | PubTator, text mining | PubMed |
| The Ongoing Struggle to Find a Gold Standard for PJI Diagnosis. | Reports (MDPI) | 2025 | 40981112 | PubTator, text mining | PubMed |
| Mechanisms, Clinical Trials, and New Treatments for BCG-Unresponsive in Nonmuscle Invasive Bladder Cancer. | Cancer Med | 2025 | 40948378 | PubTator, text mining | PubMed |
| Improving chemical synthesis and the antimicrobial activity of human defensins through disulfide bond engineering of HBD-3. | Biochim Biophys Acta Biomembr | 2025 | 40939670 | PubTator, text mining | PubMed |
| Exploring the therapeutic potential of recombinant bovine β-defensins for antimicrobial and anti-inflammatory functions in sepsis management. | Vet Res | 2025 | 40898303 | PubTator, text mining | PubMed |
| Transcriptomic changes associated with infection of Nicotiana benthamiana plants with tomato ringspot virus (genus Nepovirus) during the acute symptomatic stage and after symptom recovery. | PLoS One | 2025 | 40892828 | PubTator, text mining | PubMed |
| Difamilast induces human beta defensin 3 production via CREB and NRF2 in human keratinocytes. | J Dermatol Sci | 2025 | 40783345 | PubTator, text mining | PubMed |
| Polyploid giant cancer cells and tumor budding: translation from basic research to clinical application. | Front Oncol | 2025 | 40740858 | PubTator, text mining | PubMed |
| Vitamin D3 Modulates Inflammatory and Antimicrobial Responses in Oral Epithelial Cells Exposed to Periodontitis-Associated Bacteria. | Int J Mol Sci | 2025 | 40725246 | PubTator, text mining | PubMed |
| Targeting olfactory receptor OR2AT4: An innovative aptamer-based treatment for hair growth promotion. | Mol Ther Nucleic Acids | 2025 | 40686857 | PubTator, text mining | PubMed |
| Development of a candidate mRNA vaccine based on Multi-Peptide targeting VP4 of rotavirus A: an immunoinformatics and molecular dynamics approach. | Sci Rep | 2025 | 40594603 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55894/papers?page=3